159 related articles for article (PubMed ID: 2182016)
1. Substitutions at the P2' site of gag p17-p24 affect cleavage efficiency by HIV-1 protease.
Margolin N; Heath W; Osborne E; Lai M; Vlahos C
Biochem Biophys Res Commun; 1990 Mar; 167(2):554-60. PubMed ID: 2182016
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase.
Partin K; Kräusslich HG; Ehrlich L; Wimmer E; Carter C
J Virol; 1990 Aug; 64(8):3938-47. PubMed ID: 2196384
[TBL] [Abstract][Full Text] [Related]
3. Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2.
Tomasselli AG; Hui JO; Sawyer TK; Staples DJ; Bannow C; Reardon IM; Howe WJ; DeCamp DL; Craik CS; Heinrikson RL
J Biol Chem; 1990 Aug; 265(24):14675-83. PubMed ID: 2201691
[TBL] [Abstract][Full Text] [Related]
4. Sensitive, soluble chromogenic substrates for HIV-1 proteinase.
Richards AD; Phylip LH; Farmerie WG; Scarborough PE; Alvarez A; Dunn BM; Hirel PH; Konvalinka J; Strop P; Pavlickova L
J Biol Chem; 1990 May; 265(14):7733-6. PubMed ID: 2186027
[TBL] [Abstract][Full Text] [Related]
5. Crystallographic analysis of human immunodeficiency virus 1 protease with an analog of the conserved CA-p2 substrate -- interactions with frequently occurring glutamic acid residue at P2' position of substrates.
Weber IT; Wu J; Adomat J; Harrison RW; Kimmel AR; Wondrak EM; Louis JM
Eur J Biochem; 1997 Oct; 249(2):523-30. PubMed ID: 9370363
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease.
Erickson-Viitanen S; Manfredi J; Viitanen P; Tribe DE; Tritch R; Hutchison CA; Loeb DD; Swanstrom R
AIDS Res Hum Retroviruses; 1989 Dec; 5(6):577-91. PubMed ID: 2692658
[TBL] [Abstract][Full Text] [Related]
7. Mutating P2 and P1 residues at cleavage junctions in the HIV-1 pol polyprotein. Effects on hydrolysis by HIV-1 proteinase.
Jupp RA; Phylip LH; Mills JS; Le Grice SF; Kay J
FEBS Lett; 1991 Jun; 283(2):180-4. PubMed ID: 2044756
[TBL] [Abstract][Full Text] [Related]
8. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
[TBL] [Abstract][Full Text] [Related]
9. In vitro inhibition of HIV-1 proteinase by cerulenin.
Moelling K; Schulze T; Knoop MT; Kay J; Jupp R; Nicolaou G; Pearl LH
FEBS Lett; 1990 Feb; 261(2):373-7. PubMed ID: 1690152
[TBL] [Abstract][Full Text] [Related]
10. Recombinant HIV2 protease processes HIV1 Pr53gag and analogous junction peptides in vitro.
Pichuantes S; Babé LM; Barr PJ; DeCamp DL; Craik CS
J Biol Chem; 1990 Aug; 265(23):13890-8. PubMed ID: 2199446
[TBL] [Abstract][Full Text] [Related]
11. In vitro processing of HIV-1 nucleocapsid protein by the viral proteinase: effects of amino acid substitutions at the scissile bond in the proximal zinc finger sequence.
Tözsér J; Shulenin S; Louis JM; Copeland TD; Oroszlan S
Biochemistry; 2004 Apr; 43(14):4304-12. PubMed ID: 15065874
[TBL] [Abstract][Full Text] [Related]
12. A side chain at position 48 of the human immunodeficiency virus type-1 protease flap provides an additional specificity determinant.
Moody MD; Pettit SC; Shao W; Everitt L; Loeb DD; Hutchison CA; Swanstrom R
Virology; 1995 Mar; 207(2):475-85. PubMed ID: 7886951
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of inhibition of the retroviral protease by a Rous sarcoma virus peptide substrate representing the cleavage site between the gag p2 and p10 proteins.
Cameron CE; Grinde B; Jentoft J; Leis J; Weber IT; Copeland TD; Wlodawer A
J Biol Chem; 1992 Nov; 267(33):23735-41. PubMed ID: 1331099
[TBL] [Abstract][Full Text] [Related]
14. Sub-site preferences of the aspartic proteinase from the human immunodeficiency virus, HIV-1.
Konvalinka J; Strop P; Velek J; Cerna V; Kostka V; Phylip LH; Richards AD; Dunn BM; Kay J
FEBS Lett; 1990 Jul; 268(1):35-8. PubMed ID: 2200711
[TBL] [Abstract][Full Text] [Related]
15. Activity of tethered human immunodeficiency virus 1 protease containing mutations in the flap region of one subunit.
Tözsér J; Yin FH; Cheng YS; Bagossi P; Weber IT; Harrison RW; Oroszlan S
Eur J Biochem; 1997 Feb; 244(1):235-41. PubMed ID: 9063469
[TBL] [Abstract][Full Text] [Related]
16. Kinetic and modeling studies of S3-S3' subsites of HIV proteinases.
Tözsér J; Weber IT; Gustchina A; Bláha I; Copeland TD; Louis JM; Oroszlan S
Biochemistry; 1992 May; 31(20):4793-800. PubMed ID: 1591240
[TBL] [Abstract][Full Text] [Related]
17. Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 protease.
Tomaszek TA; Moore ML; Strickler JE; Sanchez RL; Dixon JS; Metcalf BW; Hassell A; Dreyer GB; Brooks I; Debouck C
Biochemistry; 1992 Oct; 31(42):10153-68. PubMed ID: 1420138
[TBL] [Abstract][Full Text] [Related]
18. Substrate analogue inhibition and active site titration of purified recombinant HIV-1 protease.
Tomasselli AG; Olsen MK; Hui JO; Staples DJ; Sawyer TK; Heinrikson RL; Tomich CS
Biochemistry; 1990 Jan; 29(1):264-9. PubMed ID: 2182116
[TBL] [Abstract][Full Text] [Related]
19. Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein.
Tritch RJ; Cheng YE; Yin FH; Erickson-Viitanen S
J Virol; 1991 Feb; 65(2):922-30. PubMed ID: 1987379
[TBL] [Abstract][Full Text] [Related]
20. Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites.
Griffiths JT; Phylip LH; Konvalinka J; Strop P; Gustchina A; Wlodawer A; Davenport RJ; Briggs R; Dunn BM; Kay J
Biochemistry; 1992 Jun; 31(22):5193-200. PubMed ID: 1606143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
